My bookmarksSign up free

Commission Regulation (EU) No 213/2011 ANNEX

Commission Regulation (EU) No 213/2011 ANNEX

ANNEXSupplementary provisions

ANNEX Annexes II and V to Directive 2005/36/EC are amended as follows: 1. in point 1 of Annex II, under ‘in Austria’, the following is added: ‘— special training in the care of children and young people (Sonderausbildung in der Kinder- und Jugendlichenpflege), — special training in psychiatric healthcare and nursing (Sonderausbildung in der psychiatrischen Gesundheits- und Krankenpflege), — special training in intensive care (Sonderausbildung in der Intensivpflege), — special training in intensive care of children (Sonderausbildung in der Kinderintensivpflege), — special training in anaesthesia-related nursing (Sonderausbildung in der Anästhesiepflege), — special training in renal replacement therapy related nursing (Sonderausbildung in der Pflege bei Nierenersatztherapie), — special training in operating department nursing (Sonderausbildung in der Pflege im Operationsbereich), — special training in hospital hygiene (Sonderausbildung in der Krankenhaushygiene), — special training for teaching tasks in healthcare and nursing (Sonderausbildung für Lehraufgaben in der Gesundheits- und Krankenpflege), — special training for management tasks in healthcare and nursing. (Sonderausbildung für Führungsaufgaben in der Gesundheits- und Krankenpflege), which represents education and training courses of a total duration of at least 13 years and six months to 14 years, including at least 10 years’ general education, a further three years’ basic training in the upper-grade public service for healthcare and nursing, and six to 12 months’ special training in a specialised, teaching or management task.’; 2. the following table is added to point 5.1.3 of Annex V: ‘Country Medical oncology Minimum period of training: 5 years Medical genetics Minimum period of training: 4 years Title Title Belgique/België/Belgien Oncologie médicale/ Medische oncologie   България Медицинска онкология Медицинска генетика Česká republika Klinická onkologie Lékařská genetika Danmark   Klinisk genetik Deutschland   Humangenetik Eesti   Meditsiinigeneetika Ελλάς Παθολογική Ογκολογία   España     France Oncologie Génétique médicale Ireland Medical oncology Clinical genetics Italia Oncologia medica Genetica medica Κύπρος Ακτινοθεραπευτική Ογκολογία   Latvija Onkoloģija ķīmijterapija Medicīnas ģenētika Lietuva Chemoterapinė onkologija Genetika Luxembourg Oncologie médicale Médecine génétique Magyarország Klinikai onkológia Klinikai genetika Malta     Nederland   Klinische genetica Österreich   Medizinische Genetik Polska Onkologia kliniczna Genetyka kliniczna Portugal Oncologia médica Genética médica România Oncologie medicala Genetica medicala Slovenija Internistična onkologija Klinična genetika Slovensko Klinická onkológia Lekárska genetica Suomi/Finland   Perinnöllisyyslääketiede/ Medicinsk genetik Sverige     United Kingdom Medical oncology Clinical genetics’

Read the full instrument →

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationANNEX of Commission Regulation (EU) No 213/2011 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next